Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John D Norris

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Nuclear Receptor Signaling|April 11, 2006
Single-step purification of full-length human androgen receptorDalia Juzumiene, Ching-yi Chang, Daju Fan, et al.
The Prostate|December 19, 2018
HOXB13 interaction with MEIS1 modifies proliferation and gene expression in prostate cancerDorhyun Johng, Gonzalo Torga, Charles M Ewing, et al.
Molecular Cell|May 17, 2005
Structural basis for an unexpected mode of SERM-mediated ER antagonismYa-Ling Wu, Xiaojing Yang, Zhong Ren, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 4, 2009
Inhibition of prostate cancer cell growth by second-site androgen receptor antagonistsJames D Joseph, Bryan M Wittmann, Mary A Dwyer, et al.
Molecular Cell|November 18, 2009
The homeodomain protein HOXB13 regulates the cellular response to androgensJohn D Norris, Ching-Yi Chang, Bryan M Wittmann, et al.
ACS Medicinal Chemistry Letters|July 21, 2022
A New Chemotype of Chemically Tractable Nonsteroidal Estrogens Based on a Thieno[2,3-<i>d</i>]pyrimidine CoreVamshikrishna Reddy Sammeta, John D Norris, Sandeep Artham, et al.
Molecular Endocrinology (Baltimore, Md.)|May 23, 2009
Induction of Kruppel-like factor 5 expression by androgens results in increased CXCR4-dependent migration of prostate cancer cells in vitroDaniel E Frigo, Andrea B Sherk, Bryan M Wittmann, et al.
Cancer Research|July 26, 2014
Obesity, cholesterol metabolism, and breast cancer pathogenesisDonald P McDonnell, Sunghee Park, Matthew T Goulet, et al.
Breast Cancer Research and Treatment|September 29, 2019
Pharmacokinetic and pharmacodynamic analysis of fulvestrant in preclinical models of breast cancer to assess the importance of its estrogen receptor-α degrader activity in antitumor efficacySuzanne E Wardell, Alexander P Yllanes, Christina A Chao, et al.
Breast Cancer Research and Treatment|November 18, 2019
Correction to: Pharmacokinetic and pharmacodynamic analysis of fulvestrant in preclinical models of breast cancer to assess the importance of its estrogen receptor-α degrader activity in antitumor efficacySuzanne E Wardell, Alexander P Yllanes, Christina A Chao, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Nuclear Receptor Signaling|April 11, 2006
Single-step purification of full-length human androgen receptorDalia Juzumiene, Ching-yi Chang, Daju Fan, et al.
The Prostate|December 19, 2018
HOXB13 interaction with MEIS1 modifies proliferation and gene expression in prostate cancerDorhyun Johng, Gonzalo Torga, Charles M Ewing, et al.
Molecular Cell|May 17, 2005
Structural basis for an unexpected mode of SERM-mediated ER antagonismYa-Ling Wu, Xiaojing Yang, Zhong Ren, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 4, 2009
Inhibition of prostate cancer cell growth by second-site androgen receptor antagonistsJames D Joseph, Bryan M Wittmann, Mary A Dwyer, et al.
Molecular Cell|November 18, 2009
The homeodomain protein HOXB13 regulates the cellular response to androgensJohn D Norris, Ching-Yi Chang, Bryan M Wittmann, et al.
ACS Medicinal Chemistry Letters|July 21, 2022
A New Chemotype of Chemically Tractable Nonsteroidal Estrogens Based on a Thieno[2,3-<i>d</i>]pyrimidine CoreVamshikrishna Reddy Sammeta, John D Norris, Sandeep Artham, et al.
Molecular Endocrinology (Baltimore, Md.)|May 23, 2009
Induction of Kruppel-like factor 5 expression by androgens results in increased CXCR4-dependent migration of prostate cancer cells in vitroDaniel E Frigo, Andrea B Sherk, Bryan M Wittmann, et al.
Cancer Research|July 26, 2014
Obesity, cholesterol metabolism, and breast cancer pathogenesisDonald P McDonnell, Sunghee Park, Matthew T Goulet, et al.
Breast Cancer Research and Treatment|September 29, 2019
Pharmacokinetic and pharmacodynamic analysis of fulvestrant in preclinical models of breast cancer to assess the importance of its estrogen receptor-α degrader activity in antitumor efficacySuzanne E Wardell, Alexander P Yllanes, Christina A Chao, et al.
Breast Cancer Research and Treatment|November 18, 2019
Correction to: Pharmacokinetic and pharmacodynamic analysis of fulvestrant in preclinical models of breast cancer to assess the importance of its estrogen receptor-α degrader activity in antitumor efficacySuzanne E Wardell, Alexander P Yllanes, Christina A Chao, et al.
Pageof 4